Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors

Fig. 2

Survival of the patients according to the risk scores. Kaplan-Meier curves illustrating overall survival (OS) (a) and progression-free survival (PFS) (b) according to the risk scores from zero to six. Both OS and PFS gradually decreased as the risk score increased. Thick black lines represent the risk groups

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us